SectorHealthcare Equipment and Supplies
Established Date--
Listing Date15/05/2007
ExchangeNASDAQ Stock Exchange
Full-time Employees5400
Fiscal Year Ends31/12
Security TypeCommon stock
Office address100 Nagog Park, Acton, Massachusetts 01720
Business
IntroductionInsulet Corporation is a Delaware corporation established in 2000. The Company is principally engaged in the development, manufacture and sale of its proprietary continuous insulin delivery system for patients with insulin-dependent diabetes mellitus. The Omnipod platform includes: Omnipod 5 Automatic Insulin Delivery System, Omnipod DASH Insulin Management System, Omnipod Insulin Management System and the latest innovative product Omnipod GOTM, licensed by the US Food and Drug Administration in 2023. The company also manufactures Pods for Amgen for use in Neulasta Onpro kits, a delivery system for Amgen's Neulasta that helps reduce the risk of infection after intensive chemotherapy.